知镜 Cognispect · 医学文献与研究工作台

Yerba Mate ( Ilex paraguariensis ) and Its Potential Effects on Obesity, Type 2 Diabetes Mellitus and Cardiovascular Disease: A Clinical and Preclinical Review.

Castro MC, Diaz A, Schinella G, Francini F.
Plants (Basel, Switzerland) · 2026-11-06 · PMID 43029089

文献摘要

Background Obesity, type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVDs) are growing public health problems that affect an increasing number of people worldwide because of their prevalence, costs, and health effects. Medicinal plants have preventive effects against chronic diseases, and the trend towards seeking natural products for their treatment and prevention is growing. Yerba mate (YM) is an herbal tea prepared from the dried and roasted leaves of a native South American tree, Ilex paraguariensis St. Hil. It is known for its high content of polyphenols, methylxanthines, and saponins. Methods Searches were conducted in PubMed/MEDLINE, Scopus, and the Cochrane Central Register of Controlled Trials; Google Scholar was used as a supplementary source for citation tracking and identification of potentially relevant records. For clinical trials, articles published between 2011 and 2026 were selected. Results Several studies found improvements in serum parameters, weight gain and reduced inflammation and oxidative stress in animal models. In humans, few clinical trials have been performed. They suggest positive effects on human health, decreasing waist-to-hip ratio, BMI, and improving fasting glucose, HbA1c, lipid and antioxidant serum levels, and reducing the risk of developing coronary disease. Conclusions This review integrates preclinical and clinical evidence on Ilex paraguariensis in obesity, T2DM, and CVD, with particular emphasis on the common roles of oxidative stress, inflammation, insulin resistance, and lipid dysregulation and the limitations that currently hinder clinical translation. Although YM represents a promising source of bioactive compounds and a potentially useful functional beverage, current human evidence remains insufficient to establish it as a routine treatment or preventive intervention for these cardiometabolic entities. Standardized preparations, adequately powered randomized trials, clinically relevant endpoints, and systematic long-term safety assessment are needed. By bringing these outcomes together, the review aims to distinguish mechanistic evidence from preliminary human findings and to identify priorities for standardized preparations and adequately powered clinical trials.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。